Webinar on Hepatobiliary Neoplasia Registry and Biorepository
Join us on Monday, February 11 at 12:00 p.m. eastern (9:00 a.m. pacific) for a presentation by Dr. Lewis R. Roberts from the Mayo Clinic in Rochester, MN on the three main types of studies he is performing regarding cholangiocarcinoma (bile duct cancer). Included will be details on the:
Research Plan: The collected samples will be used for three main types of studies:
1. DNA samples from patients with cholangiocarcinoma will be used for a genome-wide association study to determine the genetic variants that confer risk for cholangiocarcinoma.
2. Serum samples from patients with cholangiocarcinoma will be used to validate new biomarkers for early detection and diagnosis of cholangiocarcinoma.
3. Tissue samples obtained at surgical resection will be implanted into immunodeficient mice to create patient derived xenografts and will also be snap frozen in liquid nitrogen for future comprehensive genome-wide molecular analyses such as is performed by the National Cancer Institutes Cancer Genome Atlas Project (TCGA).
This is one of four research grants funded in 2012 by the Cholangiocarcinoma Foundation. Thank you to everyone who supports us. We could not do it without you.
More research grant webinars are scheduled for later this month. Check back for more details soon.